EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation 26-Oct-2021

Related Keywords

Geneva ,Genè ,Switzerland ,University Of Washington ,Washington ,United States ,Seattle ,Swiss ,Jim Denike ,Michael Miller ,Hans Vitzthum ,Jeff Davis ,Jack Weinstein ,Advita Lifescience Gmb ,European Patent Office ,Pharma Research ,Drug Administration ,Eqs Group ,Stock Exchange ,Swiss Exchange ,Rx Communications Group ,Holding Ag Key ,Nasdaq ,Exchange Commission ,Trademark Office ,European Medicines Agency ,Group News Service ,Acer Therapeutics Inc ,Relief Therapeutics Announce Issuance ,Urea Cycle Disorders ,Maple Syrup Urine Disease ,Chief Business Officer ,Napproved Drug Products ,Therapeutic Equivalence Evaluations ,Orange Book ,Chief Financial Officer ,Marketing Authorization Application ,Molecular Genetics ,Metabolism Reports ,Vasomotor Symptoms ,License Agreement ,Vasoactive Intestinal Peptide ,Acer Therapeutics ,Maple Syrup Urine ,Advita Lifescience Gmbh ,Private Securities Litigation Reform Act ,Quarterly Reports ,Annual Report ,Financial Officer ,Adhoc ,Relief ,Herapeutics ,Molding ,Acer ,Nnounce ,Issuance ,Patent ,Covering ,Formulation ,